Literature DB >> 28025948

Perspectives of In Vivo Bioluminescence Imaging: Application to Basic and Translational Neuroscience.

Stefanie Vogel1, Franziska M Collmann1, Mathias Hoehn2.   

Abstract

BACKGROUND: In vivo bioluminescence imaging has been used extensively for screening assays and for qualitative determination of localization of cells, in particular in cancer studies.
OBJECTIVE: In this review we show the potential of this noninvasive molecular imaging modality to investigate gene activity, dynamic processes, and translational disease processes, all under true in vivo conditions with the specific focus on brain.
RESULTS: We demonstrate a range of applications of bioluminescence imaging in basic and translational neuroscience. Here, emphasis is on the contribution of bioluminescence imaging of the brain to the elucidation of cellular and genetic mechanisms, understanding of dynamic processes, and to the discussion of disease characterization and therapeutic strategies. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  In vivo bioluminescence imaging; biological cycles; cerebral disease mechanisms; dynamic processes; neuroscience; noninvasivezzm321990molecular imaging

Mesh:

Year:  2017        PMID: 28025948     DOI: 10.2174/1381612822666161226151811

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

1.  Protocols for the Evaluation of a Lymphatic Drug Delivery System Combined with Bioluminescence to Treat Metastatic Lymph Nodes.

Authors:  Ariunbuyan Sukhbaatar; Tetsuya Kodama
Journal:  Methods Mol Biol       Date:  2022

2.  In Vivo Optical Imaging of Myelination Events in a Myelin Basic Protein Promoter-Driven Luciferase Transgenic Mouse Model.

Authors:  James Cao; Yanping Hu; Mohammed Salman Shazeeb; Carlos E Pedraza; Nilesh Pande; Daniel Weinstock; Gregory H Polites; Wenfei Zhang; Karen J Chandross; Xiaoyou Ying
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.